ResMed, Inc. (RMD)
232.49
+0.97
(+0.42%)
USD |
NYSE |
Aug 24, 16:00
232.49
0.00 (0.00%)
After-Hours: 20:00
ResMed Enterprise Value : 32.75B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 32.75B |
| August 20, 2026 | 32.30B |
| August 19, 2026 | 32.62B |
| August 18, 2026 | 31.08B |
| August 17, 2026 | 31.14B |
| August 14, 2026 | 31.73B |
| August 13, 2026 | 32.06B |
| August 12, 2026 | 31.95B |
| August 11, 2026 | 31.78B |
| August 10, 2026 | 31.09B |
| August 07, 2026 | 29.92B |
| August 06, 2026 | 31.55B |
| August 05, 2026 | 31.67B |
| August 04, 2026 | 31.54B |
| August 03, 2026 | 30.39B |
| July 31, 2026 | 29.78B |
| July 30, 2026 | 29.44B |
| July 29, 2026 | 30.26B |
| July 28, 2026 | 29.49B |
| July 27, 2026 | 28.65B |
| July 24, 2026 | 27.52B |
| July 23, 2026 | 27.03B |
| July 22, 2026 | 27.18B |
| July 21, 2026 | 27.60B |
| July 20, 2026 | 28.00B |
| Date | Value |
|---|---|
| July 17, 2026 | 28.06B |
| July 16, 2026 | 28.60B |
| July 15, 2026 | 27.99B |
| July 14, 2026 | 27.19B |
| July 13, 2026 | 27.98B |
| July 10, 2026 | 28.76B |
| July 09, 2026 | 29.42B |
| July 08, 2026 | 29.04B |
| July 07, 2026 | 31.05B |
| July 06, 2026 | 30.86B |
| July 02, 2026 | 29.59B |
| July 01, 2026 | 28.36B |
| June 30, 2026 | 27.46B |
| June 29, 2026 | 27.96B |
| June 26, 2026 | 28.23B |
| June 25, 2026 | 27.98B |
| June 24, 2026 | 27.68B |
| June 23, 2026 | 26.92B |
| June 22, 2026 | 26.51B |
| June 18, 2026 | 26.54B |
| June 17, 2026 | 26.20B |
| June 16, 2026 | 27.31B |
| June 15, 2026 | 27.13B |
| June 12, 2026 | 27.43B |
| June 11, 2026 | 27.08B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Koninklijke Philips NV | 33.32B |
| Accuray, Inc. | 176.06M |
| Medtronic Plc | 140.04B |
| Orthofix Medical, Inc. | 565.20M |
| Rockwell Medical, Inc. | 21.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 383.43M |
| Revenue (Quarterly) | 1.464B |
| Total Expenses (Quarterly) | 1.080B |
| EPS Diluted (Quarterly) | 2.645 |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 26.20% |
| Earnings Yield | 4.49% |
| Operating Earnings Yield | 5.67% |
| Normalized Earnings Yield | 4.521 |